UNSPSC 85503818: Replacement of upper artery with synthetic substitute, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to replacement of upper artery with synthetic substitute, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 03RY4JZ

UNSPSC 85503818 Replacement of upper artery with synthetic substitute, percutaneous endoscopic approach is a Commodity code that shows little relevant recent activity under its nominal scope. The six recent opportunities tagged with this code involve independent medical evaluations for pension disability determinations, surgical benefit carve-out networks, occupational medical surveillance, emergency and specialty care for detained youth, pharmacy benefit management, and temporary health professional staffing — none of which concern arterial replacement procedures or vascular surgery. The code's abstract designation does not align with what state and local governments are actually soliciting under this tag, suggesting either a data-entry mismatch in the issuing jurisdictions' procurement systems or a category misclassification.

The opportunities that do appear reflect the broader pattern of state and local procurement in occupational health, employee benefit administration, and workforce staffing. The City of Phoenix Retirement Office (Arizona), Washington State Department of Transportation, Harris County Juvenile Probation Department (Texas), the City of Long Beach (California), Collier County (Florida), and Santa Clara County Health System (California) each posted notices between July and September 2026 with response windows through October 2026. Geographic spread includes Arizona, Washington, Texas, California, and Florida. Without recent opportunities genuinely aligned to vascular surgical procedures under this code, the code does not signal actionable procurement intent for firms providing arterial replacement services or related devices to state and local buyers.